Skip to the page

Data / Form D filings / AgNovos Bioscience, Inc.

AgNovos Bioscience, Inc.: Form D filings

AgNovos Bioscience, Inc., a health care company in Rockville, MD, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on March 12, 2024, reports $13.4 million sold of a $13.4 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7301 CALHOUN PLACE, SUITE 100, Rockville, MD, 20855
Phone
(609) 319-2664
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1979715

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 12, 2024New notice$13,377,366$13,377,3668Dec 20, 2023sec.gov
Jun 9, 2023New notice$60,000,000$31,471,917$28,528,0834May 26, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
James T. HoweExecutive Officer, Director
James G. ShimpExecutive Officer
Dawn G. SvoronosDirector
James G. PilachowskiExecutive Officer
Jason G. FoleyExecutive Officer
Stephanie G. KladakisExecutive Officer
James G. BarryDirector
Falk G. DukatzExecutive Officer
Jarrett G. WaldnerExecutive Officer
Adam G. LoweExecutive Officer
James G. HoweExecutive Officer, Director
Michael G. SchmertzlerDirector
Robert G. StillerDirector
David G. StillerDirector
Nick G. ValerianiDirector
Bill G. BeasleyExecutive Officer
Chris GegeylsExecutive Officer
Ellen G. ZaneDirector

Other health care companies in Maryland that filed recently

Every Form D from the week of Mar 11, 2024 · All recent filings in Maryland · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what AgNovos Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.